Alphatec Holdings, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
An insider group, including Squadron Capital LLC and Jennifer N. Pritzker, has reduced its beneficial ownership in Alphatec Holdings, Inc. through recent open market sales.
NASDAQ
SCHEDULE 13D/A: L-5 Healthcare Partners Reduces Alphatec Warrant Exercise Price Amid Litigation Settlement, Drops Below 5% Stake
L-5 Healthcare Partners, LLC and Paul Segal have reduced the exercise price of their Alphatec Holdings, Inc. warrant to $0.01 per share as part of a litigation settlement, resulting in their beneficial ownership falling below 5%.
NASDAQ
L-5 Healthcare Partners, LLC and Paul Segal have filed an Amendment No. 9 to their Schedule 13D, reporting a continued beneficial ownership of 5.3% in Alphatec Holdings, Inc.
NASDAQ
SCHEDULE 13D/A: Major Investor Amends Stake in Alphatec Holdings, Disclosing 6.45% Beneficial Ownership
L-5 Healthcare Partners, LLC and Paul Segal have filed an Amendment No. 8 to their Schedule 13D, revealing a 6.45% beneficial ownership stake in Alphatec Holdings, Inc.